Robert F. Kennedy Jr. and his advisers are considering an overhaul of Medicare's decades-old payment formula, a bid to shift the health system's incentives toward primary care and prevention, say four people who spoke on the condition of anonymity to discuss private deliberations.

President Joe Biden's plan to authorize Medicare and Medicaid cover anti-obesity medications starting in 2026 would $140 billion over the next decade.

Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.